DSIP

Sleep: DSIP 5 mg (Delta Sleep-Inducing Peptide)

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide that has been studied for its potential role in regulating sleep and stress-related processes. Identified in 1977 from the cerebral venous blood of rabbits, DSIP has been the focus of investigations into its hypothesized impact on circadian rhythms, sleep induction, and neuroendocrine regulation. Experimental data suggest that DSIP may influence slow-wave sleep patterns and modulate activity within the central nervous system, though its exact mechanisms remain under continued investigation.

Overview

DSIP is a nonapeptide with the amino acid sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Unlike many peptides, DSIP has been proposed to cross the blood–brain barrier, a property that makes it of particular interest in sleep research. It is hypothesized to interact with multiple neurotransmitter systems, including those involving GABA, NMDA, and catecholamines, and may influence the hypothalamic-pituitary-adrenal axis. Research models suggest DSIP may modulate stress responses, influence thermoregulation, and support natural sleep architecture.

In animal models, DSIP has been linked to changes in EEG sleep stages, with findings indicating potential promotion of slow-wave sleep and stabilization of circadian rhythms. Additional investigations have explored DSIP’s proposed role in endocrine regulation, particularly in modulating secretion of luteinizing hormone and growth hormone under specific conditions.

Chemical Makeup

Molecular Formula: C35H48N10O15

Molecular Weight: 849.81 g/mol

Purity: >98%

Other Known Titles: Delta Sleep-Inducing Peptide; DSIP

Research and Clinical Studies

Sleep Regulation

Several early studies have demonstrated that DSIP may facilitate the induction of slow-wave sleep in animal models and humans. Its potential action has been attributed to interaction with sleep-promoting nuclei in the hypothalamus. Some investigations observed enhanced delta-wave EEG activity following DSIP administration, suggesting a role in deep sleep regulation.

Neuroendocrine Modulation

Research indicates DSIP may influence neuroendocrine secretion. In certain models, DSIP exposure has been associated with changes in luteinizing hormone and growth hormone release, suggesting possible hypothalamic modulation. Some data further suggest a role in reducing corticotropin and stress hormone output under specific stress conditions.

Stress and Neuroprotection

Studies have explored DSIP’s potential stress-buffering effects. Animal trials suggest that DSIP may reduce physiological markers of stress and stabilize responses to metabolic and oxidative stress. DSIP has also been investigated for potential anticonvulsant and neuroprotective properties, though these findings remain preliminary.

Metabolic and Systemic Effects

Experimental models have examined DSIP’s possible role in regulating thermoregulation, cardiovascular activity, and metabolic function. Some findings suggest potential normalization of circadian-driven fluctuations in core temperature and blood pressure, though further research is required.

References

1. Monnier M, et al. “Delta sleep-inducing peptide: a neuromodulator?” Prog Brain Res. 1977; Suppl 4:349–356. https://pubmed.ncbi.nlm.nih.gov/218903
   
2. Graf MV, Kastin AJ. “Delta sleep-inducing peptide (DSIP): a review.” Neurosci Biobehav Rev. 1986;10(4):525–542. https://pubmed.ncbi.nlm.nih.gov/2880166
   
3. Kovalzon VM. “Sleep induction by delta-sleep peptide in free-behaving rats.” Acta Physiol Acad Sci Hung. 1983;61(3):219–222. https://pubmed.ncbi.nlm.nih.gov/6317693
   
4. Kastin AJ, et al. “Delta sleep-inducing peptide: effects on endocrine function.” Pharmacol Biochem Behav. 1980;12(6):791–796. https://pubmed.ncbi.nlm.nih.gov/6256135
   
5. Sudakov KV, et al. “Neurochemical studies of DSIP.” Pharmacol Biochem Behav. 1986;25(1):27–33. https://pubmed.ncbi.nlm.nih.gov/2871959
   
6. Ohtomo H, et al. “Delta sleep-inducing peptide and stress response modulation.” J Neural Transm. 1984;60(1-2):115–122. https://pubmed.ncbi.nlm.nih.gov/6090354
   
7. Kastin AJ, et al. “DSIP: crossing the blood-brain barrier.” Peptides. 1982;3(4):757–760. https://pubmed.ncbi.nlm.nih.gov/6756613
   
8. Sudakov KV, et al. “Antistress action of delta sleep-inducing peptide.” Neurosci Behav Physiol. 1991;21(4):308–312. https://pubmed.ncbi.nlm.nih.gov/1647593
   
9. Graf MV, et al. “DSIP and neuroendocrine secretion.” Peptides. 1984;5(6):1167–1170. https://pubmed.ncbi.nlm.nih.gov/6150639
   
10. Kovalzon VM. “Delta sleep peptide: electrophysiological effects.” Physiol Behav. 1989;46(5):833–836. https://pubmed.ncbi.nlm.nih.gov/2554623